Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The TLR7/8 agonist R848 remodels tumor and host responses to promote survival in pancreatic cancer
Katherine A. Michaelis, Mason A. Norgard, Xinxia Zhu, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 172

Showing 1-25 of 172 citing articles:

Activatable polymer nanoagonist for second near-infrared photothermal immunotherapy of cancer
Yuyan Jiang, Jiaguo Huang, Cheng Xu, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 362
The Role of Macrophages in Cancer Development and Therapy
Ewa Cendrowicz, Zuzanna Sas, Edwin Bremer, et al.
Cancers (2021) Vol. 13, Iss. 8, pp. 1946-1946
Open Access | Times Cited: 249
Intratumoral immunotherapy using platelet-cloaked nanoparticles enhances antitumor immunity in solid tumors
Baharak Bahmani, Hua Gong, Brian T. Luk, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 218
Nanoparticles with ultrasound-induced afterglow luminescence for tumour-specific theranostics
Cheng Xu, Jingsheng Huang, Yuyan Jiang, et al.
Nature Biomedical Engineering (2022) Vol. 7, Iss. 3, pp. 298-312
Open Access | Times Cited: 153
Therapeutic targeting of tumour myeloid cells
Simon T. Barry, Dmitry I. Gabrilovich, Owen J. Sansom, et al.
Nature reviews. Cancer (2023) Vol. 23, Iss. 4, pp. 216-237
Closed Access | Times Cited: 147
A Defect‐Engineered Nanozyme for Targeted NIR‐II Photothermal Immunotherapy of Cancer
Deblin Jana, Bing He, Yun Chen, et al.
Advanced Materials (2022) Vol. 36, Iss. 10
Closed Access | Times Cited: 87
Decoding Toll-like receptors: Recent insights and perspectives in innate immunity
Taro Kawai, Moe Ikegawa, Daisuke Ori, et al.
Immunity (2024) Vol. 57, Iss. 4, pp. 649-673
Open Access | Times Cited: 80
Harnessing innate immune pathways for therapeutic advancement in cancer
An-Kang Hu, Li Sun, Hao Lin, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 51
pH-gated nanoparticles selectively regulate lysosomal function of tumour-associated macrophages for cancer immunotherapy
Mingmei Tang, Binlong Chen, Heming Xia, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 41
Locoregional drug delivery for cancer therapy: Preclinical progress and clinical translation
Suyog Shaha, Danika Rodrigues, Samir Mitragotri
Journal of Controlled Release (2024) Vol. 367, pp. 737-767
Closed Access | Times Cited: 20
USP19 suppresses inflammation and promotes M2-like macrophage polarization by manipulating NLRP3 function via autophagy
Tao Liu, Liqiu Wang, Puping Liang, et al.
Cellular and Molecular Immunology (2020) Vol. 18, Iss. 10, pp. 2431-2442
Open Access | Times Cited: 136
An Intelligent Biomimetic Nanoplatform for Holistic Treatment of Metastatic Triple-Negative Breast Cancer via Photothermal Ablation and Immune Remodeling
Yuanyuan Cheng, Qian Chen, Zhaoyang Guo, et al.
ACS Nano (2020) Vol. 14, Iss. 11, pp. 15161-15181
Closed Access | Times Cited: 132
Understanding the common mechanisms of heart and skeletal muscle wasting in cancer cachexia
Valentina Rausch, Valentina Sala, Fabio Penna, et al.
Oncogenesis (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 98
Pancreatic Cancer and Immunotherapy: A Clinical Overview
Florentine E. F. Timmer, Bart Geboers, Sanne Nieuwenhuizen, et al.
Cancers (2021) Vol. 13, Iss. 16, pp. 4138-4138
Open Access | Times Cited: 95
Advances in cancer cachexia: Intersection between affected organs, mediators, and pharmacological interventions
Jawed A. Siddiqui, Ramesh Pothuraju, Maneesh Jain, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2020) Vol. 1873, Iss. 2, pp. 188359-188359
Open Access | Times Cited: 82
Lipocalin 2 mediates appetite suppression during pancreatic cancer cachexia
Brennan Olson, Xinxia Zhu, Mason A. Norgard, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 78
Intratumoral combination therapy with poly(I:C) and resiquimod synergistically triggers tumor-associated macrophages for effective systemic antitumoral immunity
Clément Anfray, Francesco Mainini, Elisabeth Digifico, et al.
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 9, pp. e002408-e002408
Open Access | Times Cited: 69
Targeting toll-like receptor 7/8 for immunotherapy: recent advances and prospectives
Haowei Sun, Yingmei Li, Peng Zhang, et al.
Biomarker Research (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 68
Sonodynamical reversion of immunosuppressive microenvironment in prostate cancer via engineered exosomes
Dingyi Wang, Zhuo Wan, Qian Yang, et al.
Drug Delivery (2022) Vol. 29, Iss. 1, pp. 702-713
Open Access | Times Cited: 43
Nanocarrier Co-formulation for Delivery of a TLR7 Agonist plus an Immunogenic Cell Death Stimulus Triggers Effective Pancreatic Cancer Chemo-immunotherapy
Lijia Luo, Xiang Wang, Yu‐Pei Liao, et al.
ACS Nano (2022) Vol. 16, Iss. 8, pp. 13168-13182
Open Access | Times Cited: 41
Targeting macrophages: a novel treatment strategy in solid tumors
Mengmeng Liu, Lina Liu, Yongping Song, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 41
Tumor‐targeted nano‐adjuvants to synergize photomediated immunotherapy enhanced antitumor immunity
Hongda Zhu, Chaobo Yang, Aqin Yan, et al.
View (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 37
Application of toll-like receptors (TLRs) and their agonists in cancer vaccines and immunotherapy
Samik Chakraborty, Juan Ye, Herui Wang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 34
Azide‐Masked Resiquimod Activated by Hypoxia for Selective Tumor Therapy
Jiali Sun, Zhilin Liu, Haochen Yao, et al.
Advanced Materials (2023) Vol. 35, Iss. 29
Closed Access | Times Cited: 32
Self-delivery of metal-coordinated NIR-II nanoadjuvants for multimodal imaging-guided photothermal-chemodynamic amplified immunotherapy
Yeneng Dai, Xiangyu Li, Yuwen Xue, et al.
Acta Biomaterialia (2023) Vol. 166, pp. 496-511
Closed Access | Times Cited: 24
Page 1 - Next Page

Scroll to top